Search Results - "Maga, Tara K"

Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2 by HORAK, Christine E, JONG HEUN LEE, MELTZER, Paul S, STEEG, Patricia S, ELKAHLOUN, Abdel G, BOISSAN, Mathieu, DUMONT, Sylvie, MAGA, Tara K, ARNAUD-DABERNAT, Sandrine, PALMIERI, Diane, STETLER-STEVENSON, William G, LACOMBE, Marie-Lise

“…Exogenous overexpression of the metastasis suppressor gene Nm23-H1 reduces the metastatic potential of multiple types of cancer cells and suppresses in vitro…”
Get full text

A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome by MAGA, Tara K, MEYER, Nicole C, BELSHA, Craig, NISHIMURA, Carla J, YUZHOU ZHANG, SMITH, Richard J. H

“…Atypical hemolytic uremic syndrome (aHUS) is a complex complement-mediated disease that progresses to end-stage renal failure (ESRF) in 50% of cases…”
Get full text

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome by Maga, Tara K, Nishimura, Carla J, Weaver, Amy E, Frees, Kathy L, Smith, Richard J.H

“…Atypical hemolytic uremic syndrome (aHUS) is characterized by acute renal failure, thrombocytopenia and microangiopathic hemolytic anemia, and occurs with an…”
Get full text

A feasibility study of breast cancer genetic risk assessment in a federally qualified health center by Hoskins, Kent F., Tejeda, Silvia, Vijayasiri, Ganga, Chukwudozie, Ifeanyi Beverly, Remo, Mylene H., Shah, Hiral A., Abraham, Ivy E., Balay, Lara E., Maga, Tara K., Searles, Ericka R., Korah, Veena J., Biggers, Alana, Stolley, Melinda R., Warnecke, Richard B.

“…BACKGROUND The US Preventive Services Task Force (USPSTF) endorses routine screening for genetic risk of breast and/or ovarian cancer as a component of primary…”
Get full text

ADAMTS13 Variants in Atypical Hemolytic Uremic Syndrome by Feng, Shuju, Eyler, Stephen J., Zhang, Yuzhou, Maga, Tara K., Kroll, Michael H., Smith, Richard J.H., Afshar-Kharghan, Vahid

“…Abstract 490 Atypical hemolytic uremic syndrome (aHUS) is a clinically defined thrombotic microangiopathic anemia (TMA) characterized by the symptom triad of…”
Get full text